Darren S Cline - Net Worth and Insider Trading
Darren S Cline Net Worth
The estimated net worth of Darren S Cline is at least $17 Million dollars as of 2024-04-25. Darren S Cline is the EVP, Commercial of Seagen Inc and owns about 72,556 shares of Seagen Inc (SGEN) stock worth over $17 Million. Darren S Cline is also the Director of Pyxis Oncology Inc and owns about 10,000 shares of Pyxis Oncology Inc (PYXS) stock worth over $43,000. Details can be seen in Darren S Cline's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Darren S Cline has not made any transactions after 2021-12-08 and currently still holds the listed stock(s).
Transaction Summary of Darren S Cline
Darren S Cline Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Darren S Cline owns 6 companies in total, including Stemline Therapeutics Inc (STML) , GW Pharmaceuticals PLC (GWPH) , and Seagen Inc (SGEN) among others .
Click here to see the complete history of Darren S Cline’s form 4 insider trades.
Insider Ownership Summary of Darren S Cline
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| STML | Stemline Therapeutics Inc | 2020-06-10 | director |
| GWPH | GW Pharmaceuticals PLC | 2020-06-04 | U.S. Chief Commercial Officer |
| SGEN | Seagen Inc | 2018-11-29 | EVP & Commercial |
| PYXS | Pyxis Oncology Inc | 2021-12-08 | director |
| PLRX | Pliant Therapeutics Inc | 2023-03-06 | director |
| IMPLQ | IPI Legacy Liquidation Co | 2023-04-12 | director |
Darren S Cline Latest Holdings Summary
Darren S Cline currently owns a total of 2 stocks. Among these stocks, Darren S Cline owns 72,556 shares of Seagen Inc (SGEN) as of November 29, 2018, with a value of $17 Million and a weighting of 99.74%. Darren S Cline also owns 10,000 shares of Pyxis Oncology Inc (PYXS) as of December 8, 2021, with a value of $43,000 and a weighting of 0.26%.
Latest Holdings of Darren S Cline
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SGEN | Seagen Inc | 2018-11-29 | 72,556 | 228.74 | 16,596,459 |
| PYXS | Pyxis Oncology Inc | 2021-12-08 | 10,000 | 4.30 | 43,000 |
Holding Weightings of Darren S Cline
Darren S Cline Form 4 Trading Tracker
According to the SEC Form 4 filings, Darren S Cline has made a total of 0 transactions in Seagen Inc (SGEN) over the past 5 years. The most-recent trade in Seagen Inc is the sale of 7,000 shares on November 29, 2018, which brought Darren S Cline around $440,160.
According to the SEC Form 4 filings, Darren S Cline has made a total of 1 transactions in Pyxis Oncology Inc (PYXS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Pyxis Oncology Inc is the acquisition of 10,000 shares on December 8, 2021, which cost Darren S Cline around $93,900.
Insider Trading History of Darren S Cline
- 1
Darren S Cline Trading Performance
GuruFocus tracks the stock performance after each of Darren S Cline's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Darren S Cline is -51.76%. GuruFocus also compares Darren S Cline's trading performance to market benchmark return within the same time period. The performance of stocks bought by Darren S Cline within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Darren S Cline's insider trading performs compared to the benchmark.
Performance of Darren S Cline
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.79 | -51.76 | -73.85 | -87.3 | -55.57 | |
| Relative Return to S&P 500(%) | 8.3 | -40.48 | -61.4 | -71.61 | -54.53 |
Darren S Cline Ownership Network
Ownership Network List of Darren S Cline
Ownership Network Relation of Darren S Cline
Darren S Cline Owned Company Details
What does Stemline Therapeutics Inc do?
Who are the key executives at Stemline Therapeutics Inc?
Darren S Cline is the director of Stemline Therapeutics Inc. Other key executives at Stemline Therapeutics Inc include Chief Operating Officer Kenneth Hoberman , and Chief Medical Officer Eric K Rowinsky .
Stemline Therapeutics Inc (STML) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Stemline Therapeutics Inc (STML) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Stemline Therapeutics Inc (STML) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Stemline Therapeutics Inc (STML)'s detailed insider trading history can be found in Insider Trading Tracker table.
Stemline Therapeutics Inc Insider Transactions
Darren S Cline Mailing Address
Above is the net worth, insider trading, and ownership report for Darren S Cline. You might contact Darren S Cline via mailing address: 35 Cambridge Park Drive, Cambridge Ma 02140.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
